www.fdanews.com/articles/102315-pdl-biopharma-to-sell-busulfex-rights-for-200m

PDL BioPharma to Sell Busulfex Rights for $200M

December 17, 2007

Otsuka Pharmaceutical Co. Ltd. will acquire rights of a drug from PDL BioPharma Inc. for $200 million, the companies said Monday.
Silicon Valley/San Jose Business Journal